BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18389597)

  • 1. [Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].
    Shaposhnikova NA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (5):46-50, 164. PubMed ID: 18389597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 3. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Zinc deficiency in liver cirrhosis: a curiosity or a problem?].
    Marchetti P; Amodio P; Caregaro L; Gatta A
    Ann Ital Med Int; 1998; 13(3):157-62. PubMed ID: 9859572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of zinc metabolism in liver cirrhosis with and without encephalopathy].
    Santiago Corchado M; Ribas Ozonas B; Santos Ruiz A; Ortiz Vázquez J
    Rev Clin Esp; 1968 Jul; 110(2):109-14. PubMed ID: 5735082
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis.
    Schölmerich J; Becher MS; Köttgen E; Rauch N; Häussinger D; Löhle E; Vuilleumier JP; Gerok W
    Hepatogastroenterology; 1983 Aug; 30(4):143-7. PubMed ID: 6685108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of zinc and copper in patients with liver cirrhosis of diverse clinical severity].
    Sartori M; Calgaro M; Campanini M; Carnevale Schianca GP; De Simone GG; Dugnani M; Pozzoli G
    Minerva Med; 1988 Oct; 79(10):891-5. PubMed ID: 3185951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taste alterations in liver cirrhosis: are they related to zinc deficiency?
    Sturniolo GC; D'Incà R; Parisi G; Giacomazzi F; Montino MC; D'Odorico A; Soranzo P; Naccarato R
    J Trace Elem Electrolytes Health Dis; 1992 Mar; 6(1):15-9. PubMed ID: 1638179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic encephalopathy and colon pathology in liver cirrhosis].
    Safonova MV; Kozlova IV; Ovsiannikova VV; Kvetnoĭ IM
    Eksp Klin Gastroenterol; 2012; (6):20-6. PubMed ID: 23402187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and other trace elements in liver cirrhosis.
    Capocaccia L; Merli M; Piat C; Servi R; Zullo A; Riggio O
    Ital J Gastroenterol; 1991; 23(6):386-91. PubMed ID: 1742533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency.
    Grüngreiff K; Reinhold D
    Med Hypotheses; 2005; 64(2):316-7. PubMed ID: 15607563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood serotonin (5-HT) level and 24 hrs urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA) in patients with active liver cirrhosis and in patients with hepatic encephalopathy.
    Słomka M; Skrzydło-Radomańska B; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 1991; 46():75-80. PubMed ID: 1285400
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
    Yoshida Y; Higashi T; Nouso K; Nakatsukasa H; Nakamura SI; Watanabe A; Tsuji T
    Acta Med Okayama; 2001 Dec; 55(6):349-55. PubMed ID: 11779097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the metabolic complications of liver cirrhosis on dietary intake.
    Tözün N
    Med Sci Monit; 2000; 6(6):1223-6. PubMed ID: 11208483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with zincum metallicum CH5 in patients with liver cirrhosis. Preliminary study.
    Bădulici S; Chirulescu Z; Chirilă P; Chirilă M; Roşca A
    Rom J Intern Med; 1994; 32(3):215-9. PubMed ID: 7866338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.